- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
NICE Guidelines for Bladder Cancer Can Minimize Care Variance
NICE's first guideline on bladder cancer aims to improve the diagnosis and management of the seventh most common cancer in the UK.
There are just over 10,000 cases of bladder cancer diagnosed each year, according to figures from Cancer Research UK. It is 3—4 times more common in men than in women.
The majority of cases occur in people aged over 60, with age being the main risk factor for bladder cancer. Smoking and exposure to some industrial chemicals - such as those used in the rubber and dye industries — can also increase the risk.
Due to the number of people with the disease, the intensive treatment sometimes needed and the prolonged follow-up often done, it is thought to be one of the most expensive cancers for the NHS, but there is a wide variation across the country in terms of the treatments offered.
Link to the complete article:
Source: National Institute for Health and Care Excellence
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
